Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the PRF1A91V gene polymorphism

Hanny Al-Samkari; Gregory D Snyder; Sarah Nikiforow; Sara M Tolaney; Rachel A Freedman; Julie-Aurore Losman

doi:10.1136/jmedgenet-2018-105485

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via CCMG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via CCMG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Immunogenetics

Short report

Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the PRF1A91V gene polymorphism

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Al-Samkari H, Snyder GD, Nikiforow S, et al

Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the PRF1A91V gene polymorphism

Journal of Medical Genetics 2019;56:39-42.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password